Stockreport

Bioventus to Present at the 44th Annual J.P. Morgan Healthcare Conference

Bioventus Inc. - Class A  (BVS) 
PDF DURHAM, N.C., Jan. 06, 2026 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS), a global leader in innovations for active healing, today announced that Rob Claypoole, Ch [Read more]